HIV-associated Kaposi sarcoma research in Africa and the US
Official title: Admin Core
Funded at Lsu Health Sciences Center · NIH-11623231 · Data updated 2026-11-12
A collaborative, international effort aims to better understand and improve care for Kaposi sarcoma in people living with HIV in Africa and the U.S.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $49,950 |
| NIH project number | 3U54CA277846-04S1 |
| Project ID | NIH-11623231 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with HIV-associated Kaposi sarcoma in the participating countries who are connected to HIV care networks.
✕Less likely to help
Patients without KS or not engaged in HIV care networks may not directly benefit.
What this research studies
This program unites institutions in the U.S. and Africa to form a dedicated HIV-associated malignancy research center focused on Kaposi sarcoma. It will integrate KS diagnosis, clinical care, and research within HIV treatment networks, and explore biomarkers and viral reservoirs to inform prevention and treatment strategies. The project builds on prior collaborations to map KS across stages and treatment, and to study the immune and metabolic signals that accompany the disease. Through shared training and research activities, it seeks to strengthen local capacity and accelerate translational findings relevant to KS patients in Africa and beyond.
Why it matters
Potential benefit: If successful, patients with HIV-associated KS could gain earlier diagnosis, better-targeted therapies, and improved outcomes through enhanced care networks and biomarker-guided treatment.
How similar studies have gone: Previous collaborations have shown progress in integrating KS diagnostics and care within HIV programs, with potential for biomarker discovery informing patient management.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Wood, Charles — Lsu Health Sciences Center
- Study coordinator: Wood, Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.